November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

Home // New live Closing Session to feature crowdsourced highlights from ACR Convergence 2020

New live Closing Session to feature crowdsourced highlights from ACR Convergence 2020


1 minute

Gregg Silverman, MD
Gregg Silverman, MD

The ACR has added a special live session to ACR Convergence 2020 that will summarize the meeting’s big events and best sessions.

NBC News medical contributor Natalie Azar, MD, will host Closing Session – Bright Future: Discovery & Growth on Monday, Nov. 9, from 5 – 6 p.m. EST. Dr. Azar, assistant professor of rheumatology at NYU Langone, will interview Annual Meeting Planning Committee Clinical and Basic Science Chairs, Diane Kamen, MD, MSCR, associate professor of medicine in the Medical University of South Carolina Division of Rheumatology, and Gregg Silverman, MD, professor of medicine and pathology at the New York University School of Medicine, respectively, about the highlights from ACR Convergence.

Annual Meeting Planning Committee Chair Victoria Shanmugam, MBBS, MRCP, said on the ACR on Air podcast that the ACR Convergence organizers have been considering adding a special closing session to the meeting for many years. The change to the all-virtual meeting provided the planning committee an opportunity to introduce this concept.

Diane Kamen, MD, MSCR
Diane Kamen, MD, MSCR

Content for the closing session will be crowdsourced throughout the meeting via social media and from the Community Hubs.

“It should help us actually integrate some of these amazing networking opportunities that have come up during the meeting,” Dr. Shanmugam said. “We’re going to use that session to integrate some of the crowdsourcing, [and] get some audience participation and feedback about events that have gone on through the meeting, things that have gone on in the Community Hubs.” The session, which will be available to registered attendees on demand through March 11, 2021, also will feature ACR President Ellen Gravallese, MD, offering closing remarks about what lies ahead for rheumatology in 2021 and beyond